Warner Chilcott Share Discussion Threads

[silverfern] 20/7/2004 10:01

If I get a postive reply from Warner I will buy more but the problem of the small investor is of believing the company is sound and not resolving that belief to the reality share price- everything I know says this is cheap now, but what has prompted everyone else to sell? As I wrote WC earlier, it surely cannot be the case that fund holders sell stock just because the name of it has changed - or are they that dim?

[samuri] 20/7/2004 09:31

Very aggravating I agree, particularly after such good figures for March. Maybe there is a fear that the momentum cannot be sustained. The only answers I can suggest are:

1. Pfizers warning (and another US pharma I think) last week could impact WCRX, as bulk of revenues now generated in US.
2. JP Morgan have reiterated an overweight stance on AstraZ ahead of their results with a target price of £32. This may have prompted investors to switch from WC to AZ.
3. Market generally continues to fall.

From a charting point of view the RSI is now less than 19 indicating a very oversold position. Results for June quarter should be out mid Aug and one hopes for continued good performance with no surprises.

[matthu] 20/7/2004 09:25

I look forward to their reply. Meanwhile, WCRX have been tipped by Goodbody Stockbrokers:



Goodbody Stockbrokers is among the growing list of fans behind (Elan). Recently tipped to hit $45 Goodbody's Ian Hunter is a bit more phlegmatic about the stock, though positive it will go above $31.

Mr Hunter says that the group is beginning to return to prosperity having eliminated the high financial risks that caused its share price to plunge in 2002.

... In his assessment of the other publicly-quoted pharmaceutical stocks Mr Hunter tips Warner Chilcott as the other share buy.

[silverfern] 20/7/2004 08:49

Thanks but what on earth is going on with this share?? PS I've conatced them for an answer- will post reply

[matthu] 17/7/2004 16:05

Good to see you back!

[matthu] 14/7/2004 23:51

LONDON, July 13 (New Ratings) - Analyst Rachael Sledge of UBS upgrades Warner Chilcott from "neutral" to "buy." The target price is set to 850p.

[matthu] 08/7/2004 10:59

Where's Faz? He always had useful insight on this company!

[whitebicycle] 05/7/2004 01:34

Mine was 380p, and at the time I didn't care what the dollar was doing. At the moment I think the management couldn't give a stuff what the likes of a small UK investor thinks, they are besotted with a NAS listing. I'm out fot the moment but would appreciate a bit more visibility for the grass roots rather than a statement about a transfer of power and a listing on Nasdaq. This is more about increasing the value of director share options than share price.
I'me not convinced at the moment and would want to see some policy statement issued as to the future direction of the company and whether it intends to delist from the LSE.

[chopsy] 02/7/2004 21:24

Well it is worth watching carefully till it bottoms out (or selling or going short if you're brave enough). It looked like it might be going more horizontal just below 700, but now the downtrend has resumed again. Reasons for this?

1. Off people's radar cos its GAL no more

2. Not on US investors radar yet

3. Now a dollar earner, it will go down in £ while the dollar slides. There is a risk the dollar will weaken further if China allows its currency a free float.

On the other hand the fundamentals are very good so its push and pull. Time your entry carefully.

[silverfern] 02/7/2004 19:32

What is goign on with the share price? UNless I have missed something the price does not reflect performance - so what am I missing?

[whitebicycle] 02/7/2004 16:30

Thought I'd start the ball rolling, with a bit of luck there will be more interest than the old Galen threads.